TIAA CREF Investment Management’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

TIAA CREF Investment Management’s Portfolio AVEO Stock Details AVEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$198K	Buy	24,100 +4,058	+20%	+$41.9K	﹤0.01%	2886
2018 Q4	$321K	Hold	20,042	–	–	﹤0.01%	2749
2018 Q3	$663K	Sell	20,042 -2,536	-11%	-$65.2K	﹤0.01%	2608
2018 Q2	$510K	Buy	+22,578	New	+$535K	﹤0.01%	2779
2014 Q2	–	Sell	-24,675	Closed	-$369K	–	3213
2014 Q1	$369K	Hold	24,675	–	–	﹤0.01%	3018
2013 Q4	$454K	Sell	24,675 -7,538	-23%	-$151K	﹤0.01%	2988
2013 Q3	$667K	Sell	32,213 -963	-3%	-$22.1K	﹤0.01%	2850
2013 Q2	$829K	Buy	+33,176	New	+$1.42M	﹤0.01%	2697

Other funds holding AVEO

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

EWM

Evercore Wealth Management New York $6.36B AUM 20.35% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

TIAA CREF Investment Management's AVEO Position: Q1 2019 in Review

TIAA CREF Investment Management increased its AVEO Pharmaceuticals, Inc. (AVEO) stake by 20% in Q1 2019, buying an estimated $41.9K and bringing the position to 24,100 shares worth $198K. The position accounts for ﹤0.01% of the portfolio, ranked #2886.

TIAA CREF Investment Management first reported a position in AVEO in Q2 2013 and has held it in 8 quarters since. The position peaked at $829K in Q2 2013. 83 funds tracked by Wall St. Rank hold AVEO as of Q1 2019.

TIAA CREF Investment Management held 24,100 shares of AVEO Pharmaceuticals, Inc. worth $198K as of Q1 2019.
TIAA CREF Investment Management bought 4,058 AVEO Pharmaceuticals, Inc. shares in Q1 2019, an estimated $41.9K.
AVEO Pharmaceuticals, Inc. made up ﹤0.01% of TIAA CREF Investment Management's portfolio in Q1 2019, its #2886 holding.
TIAA CREF Investment Management first reported a position in AVEO Pharmaceuticals, Inc. in Q2 2013 and has held it in 8 quarters since.
TIAA CREF Investment Management's AVEO Pharmaceuticals, Inc. position peaked at $829K in Q2 2013.
83 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q1 2019.

Based on TIAA CREF Investment Management's 13F filing for Q1 2019, filed 14 May 2019.